title: [Our experience with panitumumab used for patients with metastatic colorectal cancer].
abstract: We report having treated patients with metastatic colorectal cancer with panitumumab in our department. Ten patients were treated. The mean age was 65. 7 years-old with 7 males and 3 females. Seven patients were treated with only panitumumab, and three patients were treated with panitumumab and another drug. The median number of infusions was 8 times. In the 9 cases that could be evaluated, the disease control rate was 66. 6%. Skin toxicity was observed in all patients. A low serum magnesium value of grade 3 was observed in one patient. We consider that treatment with panitumumab for patients with metastatic colorectal cancer was a safe option.
authors.affiliation: Dept. of Surgery, Public Central Hospital of Matto Ishikawa, Japan.
authors.forename: Kaname
authors.initials: K
authors.lastname: Ishii
authors.forename: Shunsuke
authors.initials: S
authors.lastname: Kanou
authors.forename: Ryohei
authors.initials: R
authors.lastname: Takei
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Haba
authors.forename: Yoshinao
authors.initials: Y
authors.lastname: Ohbatake
authors.forename: Masahiro
authors.initials: M
authors.lastname: Noto
authors.forename: Toshiya
authors.initials: T
authors.lastname: Takeda
authors.forename: Takashi
authors.initials: T
authors.lastname: Tani
authors.forename: Masao
authors.initials: M
authors.lastname: Yagi
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D000077544:Panitumumab
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077544:Panitumumab